Drug recall · May 6, 2026
Levocarnitine Injection recall
Why: Labeling: Missing Label
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01
- Lots / codes
Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027
- Quantity
- 74,040 Single Dose Vials
- Company
- American Regent, Inc., New Albany, OH
- Distribution
- U.S. Nationwide
- Initiated
- April 16, 2026 · Voluntary: Firm initiated
- Classified
- April 28, 2026
- Reported
- May 6, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levocarnitine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.